In primary cultures of porcine proximal tubular kidney cells and LLC-PK1 cells cisplatin (5 ± 50 mM) caused apoptosis and cell detachment; in both systems cell detachment occurred, preceded by a loss of cytoskeletal F-actin stress fibers within 4 ± 6 h, and a reduction of mRNA encoding for fibronectin, collagen a 2 type (IV) and laminin B2 within 17 ± 41 h. Prevention of F-actin damage by phalloidin prevented nuclear fragmentation, suggesting a relation between F-actin damage and apoptosis. Overexpression of Bcl-2 also prevented apoptosis, but did not prevent damage to the F-actin skeleton or the reduction of mRNA expression of the matrix proteins. These results suggest that Bcl-2 overexpression interferes with apoptotic signals downstream of F-actin. The relevance of these results for cell detachment in kidney toxicity is discussed.
Introduction
Cisplatin, one of the most effective chemotherapeutic agents currently available, is used in the treatment of a wide range of neoplasms (Prestayko et al, 1980) . The major side-effects of cisplatin-treatment are acute and chronic nephrotoxicity. Acute toxicity, characterized by necrosis in the S 3 segment of the proximal tubule, has been studied extensively in laboratory animals. In humans, the pattern of cisplatin nephrotoxicity is similar, starting with acute proximal tubular dysfunction (Daugaard, 1990) The long-term effects of cisplatin on renal function are less well understood, especially the events leading to acute renal failure (ARF). Interestingly, exfoliated but still viable proximal tubular cells are observed in urine of cisplatin-treated patients suffering from ARF (Lam and Adelstein, 1986) .
Although chemical-induced ARF is called`acute tubular necrosis', little necrosis is observed in S 1 and S 2 segments of the tubules. Instead, gaps are found in the epithelium along the tubular basement membrane at sites where cells have exfoliated, together with regenerative changes in the adjacent tubular cells (Solez, 1991) . Detachment of proximal tubular cells may contribute to the pathophysiology of ARF in three ways. First, loss of cells may lead to altered transport properties and abnormal tubular reabsorption. Secondly, detached tubular cells can cause tubular obstruction. Finally, at sites with a denuded basement membrane, the ultrafiltrate can leak back from the tubular lumen into the circulation (Andreucci, 1984) .
Proximal tubular cells are attached to the basement membrane in vivo (and to the growth support in vitro) by means of the integrin family of cell surface receptors, consisting of two subunits (a and b) with domains on both sides of the cell membrane. The cytoplasmic domain interacts with the F-actin fibres of the cytoskeleton through talin, vinculin and a-actinin, while the extracellular domain interacts with the extraceilular matrix (ECM), thus mediating cell adhesion (Zhang et al, 1995) . Consequently, damage to F-actin or changes in ECM integrity can cause detachment of the cells. Changes in the expression level of integrins do not necessarily lead to epithelial cell detachment (Gallit et al, 1993) .
In this study we investigated whether changes in F-actin and/or ECM production are involved in cell detachment induced by cisplatin. A reduction of cell-ECM contacts can cause apoptosis also known as`anoikis' (Frisch et al, 1996) , since the intact ECM-integrin contact sends a continuous anti-apoptotic signal to the cell (Ruoslahti, 1996) . Also, an association between loss of a functional cytoskeleton and apoptosis has been shown recently (Brown et al, 1997; Van de Water et al, 1996) ; therefore, we investigated the relation between cisplatin-induced Factin damage and apoptosis.
To investigate the effects of cisplatin on F-actin, ECM component expression, cell detachment and apoptosis we used cultured porcine proximal tubular cells (PPTC), a model for human PTC that we characterized previously (Kruidering et al, 1994; , and the porcine renal proximal tubular cell line LLC-PK1, The data show that reduced production of ECM components and F-actin damage was associated with cell detachment of viable, necrotic and apoptotic cells. Prevention of F-actin damage prevented apoptosis. Apoptosis could also be prevented by overexpression of the anti-apoptotic oncogene bcl-2, but this did not block F-actin rearrangement nor the decrease of production of ECM components, implying that Bcl-2 affected apoptotic messengers downstream of F-actin signalling.
Results

Effects of cisplatin on cell adhesion and viability
Exposure of a monolayer of PPTC to 10 ± 50 mM cisplatin for 17 h induced morphological alterations of the cells: they were rounded, smaller and appeared darker when analyzed by phase contrast microscopy. The number of cells with morphological alterations increased with cisplatin concentration. The monolayers exposed to 25 and 50 mM cisplatin displayed some cell swelling, suggesting necrotic cell death. At this time point (17 h) no significant cell detachment had taken place. Exposure for 41 h induced a concentrationdependent disruption of the monolayer; the cells detached individually (Figure 1a ± d, Table 1 ). Empty areas with complete detachment of cells could be observed, while other cells remained attached to the dish, suggesting loss of cellcell contact. Part of the cells had shrunk and were fully rounded but still attached to morphologically normal, adherent cells.
In the adherent cells, cisplatin induced a concentrationdependent decrease of viability: at 50 mM cisplatin viability was decreased by almost 50% after 41 h (Table 1) . Most, but not all of the detached cells were non-viable as determined by PI staining and flowcytometric analysis (Table 1) .
a b c d Figure 1 Phase contrast photomicrographs of PPTC exposed to cisplatin for 41 h. Unexposed PPTC (A) display the cobblestone morphology of normal epithelial cells and exclude PI and trypan blue. Shown are PPTC exposed to O mM (A), 10 mm (B), 25 mM (C) and 50 mM cisplatin (D) for 41 h. Note the empty areas in monolayers exposed to 25 and 50 mM cisplatin (C and D)
Exposure of the monolayers to 250 ± 500 mM cisplatin induced rapid cell swelling and death (necrosis) within 17 h (not shown).
Cisplatin-induced cell death of PPTC: apoptosis and necrosis
Cisplatin has been shown to induce both necrosis and apoptosis in mouse PTC in vitro (Lieberthal et al, 1996) . We investigated the type of cell death using ethidium bromide (EtBr) and acridine orange (AcOr), allowing identification of viable, apoptotic and necrotic cells, based on colour and appearance. Viable cells take up AcOr, giving them a green colour. Non-viable cells take up EtBr, giving thern an orange colour. Both dyes intercalate into DNA allowing separation of four populations: (I) viable cells: green cells with intact nucleus; (II) early apoptotic cells: green cells with a fragmented nucleus; (III) late apoptotic cells: orange cells with a fragmented nucleus, and (IV) necrotic cells: orange cells with normal appearing nuclear structure (Lieberthal et al, 1996) .
Whereas high concentrations (500 mM cisplatin) induced rapid cell death by necrosis, 50 mM and lower concentrations induced morphological changes in the nucleus characterized by condensed or a fragmented nucleus, associated with apoptosis ( Figure 2 ). Cells exposed to 5 ± 50 mM cisplatin displayed both early (green) and late (orange) apoptotic morphology after staining with AcOr and EtBr (Figure 3 ). The percentage of apoptotic cells is shown in Table 2 . In monolayers exposed to 5 and 10 mM cisplatin only 4 ± 9% of the cells were necrotic. At higher concentrations, i.e. 50 mM and 500 mM, the percentage of necrosis increased to 25+14% (Table 2 ) and 87+3% respectively. The percentage of apoptotic cells of the detached cell population was also assessed. Approximately 40% of the detached cells of unexposed monolayers was apoptotic; this percentage was similar to that of detached cells from monolayers exposed to 5 ± 50 mM cisplatin (Table 3) , although at increasing cisplatin concentration an increasing percentage of the cells detached (Table 1) . At cisplatin concentrations above 50 mM the detached cells were predominantly necrotic.
Effects of cisplatin on the cytoskeleton: F-actin and microtubules
Renal epithelial cells possess F-actin fibres located at the basolateral side of the cells, known as stress fibres, and an apical pool of actin involved in formation of adherent junctions. Exposure to cisplatin induced a concentration-and timedependent loss of stress fibres, accumulation of F-actin in the junctional ring and finally total depolymerization of Factin. Moreover, as cells lost their stress fibres, they detached from each other. Most of the cell-cell contact was lost and reduced to a few contacts at the cell surface. Loss of stress fibres was dependent on the concentration of cisplatin and exposure time. When PPTC were exposed to 5 mM cisplatin, stress fibres were thinner or lost after 24 h and the F-actin fibres in the cytosol were thinner and shorter than in control cells (Figure 4b ). After a 24 h exposure to 10 mM cisplatin, all stress fibres were lost. Higher concentrations, i.e. 50 ± 250 mM, induced total loss of stress fibres within 3 ± 24 h ( Figure 4c ); yet actin filaments did accumulate at the cortical cytoskeleton. At 500 mM cisplatin, PPTC had lost almost all F-actin within 4 h, probably through depolymerization (Figure 4d) . Interestingly, the effect of cisplatin was specific for actin fibres: we did not find any effect on microtubules within 48 h (not shown).
Effects of clisplatin on ECM mRNA levels
Attachment of PTC is mediated via integrins, which connect Factin to the ECM. Since PTC produce their own ECM, we therefore investigated whether cisplatin decreased production of components of the ECM, eventually resulting in celldetachment.
Exposure of PPTC to 10 mM cisplatin for 17 h reduced the mRNA levels of laminin (LN) and fibronectin (FN) to 53+13 and 50+28%, respectively. Higher cisplatin concentrations reduced these levels further ( Table 4 ). The collagen a 2 type (IV) mRNA (COL) level was not significantly decreased after 17 h, but within 41 h 10 and 50 mM cisplatin reduced the level of COL mRNA to 70+14 and 30+20%, respectively (Table 4 ). All mRNA values were calculated relative to the GAPDH glyceraldehyde 3-phosphate dehydrogenase mRNA level (a gene coding for a house-keeping enzyme). The GAPDH mRNA levels did not decrease significantly within 41 h: the maximal observed decrease was 10%. The observed decreases of the other mRNA's are therefore not due to cell death.
Importantly, the effect on mRNA levels preceded cell detachment: after 17 h of exposure to 10 ± 50 mM cisplatin no significant cell loss could be observed and monolayers were still intact. Figure 3 Fluorescence photomicrographs of nuclei of PPTC cells stained with EtBr and AcOr. Cells were identified based on colour and appearance. Viable cells take up only acridine orange (AcOr), giving them a green colour. Nonviable cells also take up ethidium bromide (EtBr), giving them an orange colour, visible as more intense fluorescence in this picture. In (A) PPTC exposed to 10 mM cisplatin are shown. The faintly coloured cells are green (viable). The two most brightly coloured cells are orange, one necrotic (N) and one late apoptotic (LA). Note the condensed chromatin in the apoptotic cell. In (B) monolayers exposed to 50 mM cisplatin are shown. All cells in this picture are orange. Both necrotic (N) cells with normal nuclei and late apoptotic (LA) cells are present, with brightly fluorescent condensed chromatin 
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The monolayers were rinsed with HH buffer 2% BSA and the¯oating cells were pooled and stained with 10 mM EtBr and AcOr. Cells were analyzed immediately using VIFM. Values are expressed as percentage of total+S.E.M. (n = 6). *signi®cantly different from control (P < 0.05)
Role of F-actin in cisplatin-induced nuclear changes
Since cisplatin induced F-actin damage prior to changes in nuclear morphology, we investigated the relationship between F-actin disorganization and apoptosis. All cells treated with any cisplatin concentration that displayed an altered nuclear morphology had lost their F-actin fibres, while in all cells with unchanged nuclei F-actin fibres were still intact. When PPTC were exposed to 20 mM cytochalasin D, to disrupt F-actin filaments, nuclear fragmentation was also detected ( Figure  5e ). To further study the role of F-actin disorganization, the effect of phalloidin, an F-actin stabilizing compound, on PPTC treated with 5 mM cisplatin was tested. At 5 mM phalloidin blocked the disappearance of F-actin stress fibres ( Figure 5 ). This was associated with a significant reduction in the extent of cell death, which could be accounted for by inhibition of apoptosis (Table 5) .
At 10 mM cisplatin, however, phalloidin failed to stabilize F-actin structures in the cells: the F-actin cytoskeleton was damaged in spite of the presence of phailoidin. This was associated with lack of protection against apoptosis.
Effects of cisplatin on the LLC-PK1 cell lines
Since Bcl-2 is a potent anti-apoptotic protein, capable of preventing apoptosis induced by a variety of triggers in a wide range of cells (Vaux and Weissman, 1993) , we investigated if A B C D Figure 4 Fluorescence photomicrographs demonstrating the effect of cisplatin on F-actin fibres. PPTC were exposed to various concentrations cisplatin for the indicated times, rinsed with PBS and fixed. Subsequently F-actin was visualized. Control cells (A) display stress fibres. Exposure to 5 mM for 24 h results in thinner fibres than control (B), while 50 ± 500 mM results in loss of all fibres after 3 ± 6 h (C); note the intactness of the junctional actin visible as a ring around the cell. PPTC exposed to 500 mM for 4 h also lost the junctional actin (D) Cisplatin-induced cell detachment and apoptosis M Kruidering et al the bcl-2 gene product could protect renal ceIls from cisplatininduced toxicity. We used an LLC-PK1 cell overexpressing Bcl-2 in a zinc-inducible system (`BCL2'), and a neomycin resistance-transfected PK1 cell line as control (`NEO').
Before studying the role of Bcl-2 in cisplatin toxicity in LLC-PK1 cells, we repeated all experiments described above for PPTC in the LLC-PK1 tell lines, in order to confirm that cisplatin exerted the same effects in both cell systems. Cisplatin showed essentially the same effects on cell adhesion and viability, damage to the F-actin cytoskeleton and extent of apoptosis and necrosis. The only difference was observed in expression of the mRNA encoding for collagen: in contrast to the lack of effect in PPTC, cisplatin reduced COL mRNA levels in the LLC-PK1 cell lines to the same extent as the levels of mRNA encoding for FN ( Figure 6 ).
Overexpression of Bcl-2 in the LLC-PK1 cell line
Exposure to 100 mM ZnSO 4 , required to induce Bcl-2 in the BCL2 cell line, completely prevented the cisplatin-induced changes in nuclear morphology in the three LLC-PK1 cell lines. Therefore, this did not allow conclusions as to the role of Bcl-2. To avoid this, Bcl-2 induction was performed by preincubation of the cells with 100 mM ZnSO 4 for 48 h; subsequently the cells were exposed to cisplatin after removal of ZnSO 4 .
In order to confirm that ZnSO 4 pretreatment did result in an upregulation of Bcl-2 after ZnSO 4 removal, we analyzed the Bcl-2 content after removal of ZnSO 4 . Exposure of the BCL2 cell line to 100 mM ZnSO 4 for 48 h resulted in an increased amount of the 25 kDa Bcl-2 protein after 24 ± 48 h (Figure 7 : lanes 9 ± 12); the Bcl-2 level increased to 250+22% of control at 48 h. After removal of ZnSO 4 , Bcl-2 slowly declined, but it was still elevated in comparison with control cells after 48 h (Figure 7 : lanes 13,14): after 24 h the Bcl-2 content was 200+18% and after 48 h it was 157+12%.
Prevention of nuclear fragmentation by Bcl-2
Exposure of the control LLC-PK1 cell line and the control transfected`NEO' cell line to 50 mM cisplatin for 48 h subsequent to the ZnSO 4 treatment gave identical results as in PPTC: 58+10% of the cells displayed a fragmented nuclus. After staining the condensed and fragmented nuclei were visible as intensely fluorescent clumps (Figure 8b ). EtBr and AcOr staining revealed that the ratio early/late apoptotic cells was not changed after ZnSO 4 pre-treatment (not shown), demonstrating that this ZnSO 4 pre-incubation did not interfere with the nuclear fragmentation.
Induction of Bcl-2 by ZnSO 4 in the BCL2 cell line resulted in a reduction of the percentage of apoptotic cells from 67 ± 20% (Figure 9 ). This protection from cisplatininduced apoptosis is illustrated in Figure 7c . However, the protection by Bcl-2 was not complete since 20+5% of the cells of the monolayer still displayed a degraded nucleus, indicative of (early and late) apoptosis (Figure 8d ). The fact that protection is not observed in all cells may be due to the fact that the amount of Bcl-2 protein started to decrease immediately after the removal of ZnSO 4 , so that some cells may in fact be below a critical minimum level of Bcl-2 protein.
Effect of Bcl-2 induction on cisplatin-induced F-actin damage and ECM production
To test whether Bcl-2 cytoprotection was related to protection against F-actin rearrangement we investigated the effect of Bcl-2 overexpression on cisplatin-induced F-actin damage.
After preincubation with 100 mM ZnSO 4 , the cisplatininduced F-actin damage in BCL2 cells was identical to the damage in control cells and in BCL2 cells without ZnSO 4 pre-incubation (Figure 10 ), demonstrating that Bcl-2 overexpression had no effect on cisplatin-induced F-actin damage. Similarly, expression of Bcl-2 did not affect the cisplatin induced effects on ECM production ( Figure 6 ).
Discussion
This study provides evidence that F-actin damage may contribute to cisplatin-induced nephrotoxicity. Low concentrations of cisplatin (5 ± 10 mM), that did not induce necrosis, caused the loss of stress fibres in PPTC and LLC-PK1 cells within 24 h; higher concentrations induced more severe effects in a shorter time. Since F-actin is continuously formed and degraded, cisplatin might affect either process. Zeng et al (1996) showed that 10 ± 300 mM cisplatin merely inhibited polymerization, suggesting that at the lower concentration of cisplatin in our setting (and also in vivo), inhibition of polymerization and severing of F-actin filaments into smaller ones, are the main causes of cisplatin-induced F-actin damage. This is confirmed by the observation that only at higher concentrations (50 ± 500 mM cisplatin) an increase in soluble G-actin was observed, presumably caused by complete depolymerization (data not shown).
F-actin damage may contribute to nephrotoxicity in two ways. Firstly, F-actin damage may cause an increased monolayer permeability, as shown for mouse PTC in culture with a loss of stress fibres (Kroshian et al, 1994) . Secondly, the cytoskeleton, especially the F-actin network, has been implicated in maintenance of cell attachment in a variety of Figure 5 The effect of phalloidin on F-actin and apoptosis in PPTC. The fluorescence photomicrographs illustrate the relation between F-actin fibres and onset of apoptosis in PPTC. PPTC exposed to 5 mM cisplatin for 48 h loose stress fibres (A) and in some nuclei chromatin degradation is observed (B). PPTC exposed to cisplatin + 2 mM phalloidin, preserve stress fibres (C), which prevents the nucleus from chromatin degradation (D). In (E) nuclei of PPTC exposed to 20 mM cytochalasin D are shown displaying nuclear fragmentation Cell detachment may also be caused by a direct effect on the integrins or ECM. Since cisplatin is known to inhibit RNA and protein synthesis (Kondo et al, 1995) and Goligorsky and co-workers (Gallit et al, 1993) showed that integrin levels were not reduced in detached cells, we hypothesized that a reduced ECM expression might contribute to renal cell detachment by cisplatin. Our results show that exposure of PPTC and LLC-PK1 cells to sublethal concentrations of cisplatin reduced the expression of mRNA encoding for fibronectin, laminin, and collagen IV a 2 . While in PPTC COL mRNA levels were not affected within 17 h, in LLC-PK1 cells COL mRNA levels were decreased at this time-point. The reason for this difference between primary cultured PTC and the LLC-PK1 cells remains unclear and may be a consequence of the immortalization of the LLC-PK1 cells. The reduction in mRNA levels preceded changes in cell morphology and detachment, implying that reduced mRNA production of ECM components with subsequent reduced integrin binding may contribute to cisplatin-induced renal cell detachment. Since the mRNA levels are calculated relative to GAPDH levels, a housekeeping gene, which did not decrease significantly during the experiment, we conclude that the cisplatin-induced reduction in mRNA levels is not just a consequence of cell death, cell detachment or overall non-specific reduction of mRNA. However, the synthesis of other proteins may be inhibited as well. The ECM-integrin contact is essential for prevention of apoptosis known as`anoikis' (Frisch et al, 1996; Ruoslahti, 1996) by increasing levels of Bcl-2 in the case of a5, b1
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integrin (Zhang et al, 1995) . In concordance, we found that cisplatin induced loss of F-actin fibres, and reduction of mRNA levels encoding for ECM components was accompanied by apoptosis.
Our data provide evidence that the onset of cisplatininduced nuclear fragmentation is, at least in part, dependent on cytoskeletal damage. First of all, F-actin damage occurred prior to the changes in nuclear morphology. Secondly, prevention of F-actin damage in viable cells by phalloidin prevented the formation of fragmented nuclei. Finally, control experiments with cytochalasin D that specifically induces Factin damage caused similar nuclear fragmentation. This is in concordance with a relation between F-actin and apoptosis described for rat PTC (van de Water et al, 1996) and neutrophils (Brown et al, 1997) .
Exactly how F-actin damage is involved in the onset of apoptosis remains to be elucidated. Zhang et al (1995) have shown that some integrins can suppress apoptosis via the Bcl-2 pathway. Moreover, Hsu et al (1997) showed that subcellular localization of members of the Bcl-2 family changed during apoptosis. Based on this as well as on our present results it could be postulated that F-actin is involved in the maintenance of the concentration or subcellular A B C D Figure 8 Fluorescence photomicrographs of nuclei of PK1 and BCL2 cells stained with Hoechst 33458. After 48 h of exposure to 100 mM ZnSO 4 , cells were exposed to 0 (control) or 50 mM cisplatin for 48 h, rinsed with PBS, fixed and stained. Depicted are control (A), nuclei of PK1 cells, PK1 cells exposed to 50 mM cisplatin (B) and BCL2 cells exposed to 50 mM cisplatin after induction of bcl-2 (C). Note the condensation of the chromatin and degradation, resulting in an intense staining, characteristic for apoptosis in B, which was observed in all cell lines. Prevention of apoptosis by bcl-2 (C) was not complete since in some parts of BCL2 cells exposed to cisplatin after ZnSO 4 exposure, apoptotic cells were observed (D) Figure 7 Immunoblot analysis of bcl-2 in control transfected (NEO) and bcl-2 transfected (BCL2) cells during and after induction with 100 mM ZnSO 4 for 48 h. Start of ZnSO 4 treatment is t=0, and (48+24) distribution of members of the Bcl-2 family, when Bcl-2 is expressed at physiological levels. However, although Haidar et al (1997) demonstrated that drugs that disrupt cytoskeletal integrity cause apoptosis via inactivation of Bcl-2; they also showed that cisplatin does not use this Bcl-2 pathway. This favours the hypothesis that apoptosis associated with F-actin damage is the consequence of altered integrin signalling. Clearly, further studies are needed to confirm this hypothesis. Prevention of cisplatin-induced F-actin damage suppressed nuclear fragmentation, but prevention of nuclear fragmentation by Bcl-2 occurred without reduction of the damage to F-actin. Therefore, it can be postulated that F-actin damage is an early, and nuclear degradation a later process of the`apoptotic' pathway. Thus, overexpression of Bcl-2 prevented apoptosis without affecting the`upstream', F-actin damage signal. In spite of the functional relation between F-actin damage and apoptosis, our results also reveal that damage does not necessarily cause apoptosis, since also non-apoptotic, viable cells detached.
Because of the physiological similarities of the kidneys of pig and man, the results obtained with PPTC seem more relevant to man than results obtained from rodent models. The results regarding cisplatin-induced cell detachment and apoptosis may have clinical relevance, since plasma levels of approximately 10 mM cisplatin were reported for patients at the end of a 6 h infusion of 80 mg/m 2 (Fish et al, 1994a) . This study demonstrates that at this concentration, cisplatin induces cell detachment and changes in nuclear morphology of renal cells, suggesting a contribution of these processes to renal dysfunction, associated with cisplatin therapy.
In conclusion, we demonstrated that cisplatin induces damage to the F-actin cytoskeleton and reduces expression of mRNA encoding forCOL, FN and LN in renal cells.
Together, these effects may cause cell detachment and changes in nuclear morphology associated with apoptosis. This can be overcome at low concentrations by preventing F-actin damage and by overexpression of Bcl-2 at all Figure 10 Fluorescence photomicrographs demonstrating the effect of cispiatin on F-actin fibres. BCL2 cells were exposed to 50 mM cisplatin for 48 h, rinsed with PBS and fixed. Subsequently F-actin was visualized. Control cells (A) display stress fibres. Exposure to 50 mM cisplatin (48 h) causes loss of F-actin stress fibres (B). After induction of bcl-2 in the BCL2 cells, subsequent exposure to cisplatin still causes loss of stress fibres (C) concentrations inducing nuclear fragmentation (i.e. 5 ± 50 mM).
In vivo, both processes may eventually result in tubules with denuded basement membranes and thus contribute to cisplatin-induced renal dysfunction and ARF, as is schematically depicted in Figure 11 .
Materials and Methods
Chemicals
Bovine serum albumin (BSA), collagenase (EC 3.4.24.3) (from Clostridium histolyticum), cis-diamine-dichloroplatinum (II) (cisplatin), ethyleneglycol-bis-(b-aminoethylether)-N,N,N',N,-tetraacetic acid (EGTA), sodium deoxycholate (DOC), phenylmethylsulfonyl fluoride (PMSF), phalloidin, trypsin inhibitor type II-T (from turkey egg white) ethidium bromide (EtBr) were from Sigma Chemical Co. (St Louis, MO, USA). N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), sodium pyruvate, RNAse A, nonidet P-40 (NP-40), sodium pyruvate and monoclonal mouse anti BCL-2 (clone 104) and proteinase K were obtained from Boehringer Mannheim (Mannheim, Germany). Nycodenz (lohexol) was from Nycomed AS (Oslo, Norway). Acridine orange (AcOr), bodipy-phalloidin and propidium iodide (PI) were from Molecular Probes (Eugene, OR, USA). Peroxidase-conjugated antimouse IgG was from Jackson Immuno Research Labs (West Grove, PA, USA). The enhanced chemiluminescence method (ECL) kit was from Amersham Laboratories (Buckinghamshire, UK). Fluorescentlabelled goat anti-mouse IgG was from Caltag Laboratories (San Francisco, CA, USA).
Chemicals for cell culture Defined bovine calf serum (BCS) (supplemented) was from HyClone Laboratories Inc. (Logan, UT, USA). Penicillin G was from Gist Brocades (Delft, The Netherlands). Ciprofloxacin from Bayer AG (Leverkusen, Germany). Amphotericin B from Bristol-Myers Squibb BV (Rijswijk, The Netherlands). All other chemicals used for cell culture were from Sigma.
Isolation and culture of porcine proximal tubular cells (PPTC)
Cell isolation of PPTC was performed as described before (Kruidering et al, 1997) . The final cell preparation, lacking distal tubular and endothelial cells (Kruidering et al, 1994) , had a viability of over 90% and contained routinely 90% cells that were positive for g-glutamyl transpeptidase (GGT), indicating that they were proximal tubular cells.
The cells were cultured in Dulbecco's modified eagle's medium (DME) DME/F12 supplemented with 6 pM 3,3',5, triiodothyronine, 5 mg/l transferrin, 10 mg/l epidermal growth factor, 100 nM hydrocortisone, 28 nM prostaglandin E 1 , 29 nM sodium selenite, 1 nM retinoic acid, 100 units/l insulin, 50 nM dexamethasone, 10 5 units/l penicillin G, 2.5 mg/ 1 amphotericin B, 4 mg/l ciprofloxacin, 2 mM Lglutamine, 1.1 mM pyruvate and 10% serum as described previously (Kruidering et al, 1994) . The cultures were maintained at 378C in a humidified 95% air/5% CO 2 atmosphere. The medium containing 10% (v/v) serum and hormones was replaced by serum-free medium with hormones after reaching confluence; the latter was replaced every 2 days. Cells were cultured on collagen (40 mg/ml from rat tail, Type I Sigma) coated coverslips in six well culture plates for histochemistry and in collagen coated 75 cm 2 culture flasks for RNA isolation. Growth and morphology of the cells were monitored using a Nikon TMS Reversed Microscope equipped with phase contrast optics. PPTC were used 1 ± 2 days after reaching confluence (5 ± 6 days after plating).
Morphological, biochemical and immunohistochemical characterization demonstrated that the cells were of proximal tubular origin and that the PPTC retained a brush border as well as GGT and alkaline phosphatase activity in culture; they expressed keratin and FX1A (Kruidering et al, 1994) .
Cell lines
Three cell lines were used: the LLC-PK1 cell line, designated PK1; a LLC-PK1 cell line transfected with a control vector, carrying only the neomycin resistance, designated`NEO'; and a LLC-PK1 cell line which was transfected with a human bcl-2 construct (Vaux and Weissman, 1993) , cloned in the pVZ1 vector (Henikoff and Eghtedarzadeh, 1987) with a zinc-inducible promotor, designated`BCL2'. The cell lines were cultured in DME supplemented with 10 5 U/I penicillin, 5 mg/ml streptomycin, 100 mg/ml geneticin and 10% (v/v) serum. The cultures were maintained at 378C in a humidified 95% air/5% CO 2 atmosphere. Experiments were performed with passages 203 ± 211. Growth and morphology of the cells were monitored using a Nikon TMS Reversed Microscope equipped with phase contrast optics. For fluorescence analysis of the nucleus and cytoskeleton, cells were cultured on collagen-coated coverslips, and for RNA isolation in collagen coated 75 cm 2 culture flasks.
Detection of Bcl-2 by gel electrophoresis and immunoblotting
In order to induce Bcl-2 expression, confluent monolayers of cells cultured in 6 cm culture dishes were exposed to 6 ml 100 mM ZnSO 4 in DME for 24 ± 48 h in a humidified 95% air/5% CO 2 atmosphere. After exposure, the cells were washed four times with 10 ml Hanks-HEPES buffer pH 7.4, consisting of 137 mM NaCl, 5 mM KCl, 0.8 mM MgSO 4 , 0.4 mM Na 2 HPO 4 , 0.4 mM KH 2 PO 4 , 1.3 mM CaCl 2 and 5 mM glucose (HH buffer), and incubated for another 24 ± 48 h in HH buffer at 378C in a 95% air/5% CO 2 atmosphere. At the indicated times, cells from a 6 cm culture dish were washed three times with ice-cold PBS, scraped into 250 ml immunoprecipitation buffer (IPB.7 buffer), consisting of Figure 11 Scheme of cisplatin-induced effects on renal cells causing cell detachment, increased tubular permeability eventually leading to acute renal failure 20 mM tri-ethanolamine, 0.7 M NaCl, 0.5% (v/v) NP-40, 4.6 mM sodium deoxycholate, 1 mM PMSF, 0.01% (w/v) trypsin inhibitor (II-T), pH adjusted to 7.8 with HCl. Directly after scraping, samples were frozen in liquid nitrogen and stored at 7808C. SDS ± PAGE was performed according to Laemmli (1970) . After thawing, the samples were diluted in sample buffer to a protein concentration of 1 mg/ml, heated for 10 min at 808C and loaded onto 10% SDS polyacrylamide gels. After electrophoresis proteins were transferred to nitrocellulose membranes. After blocking with 5% (w/v) fat-free dried milk, the membranes were incubated overnight with anti Bcl-2 antibody (1 : 40). After washing, the filters were incubated with peroxidase-conjugated anti-mouse lgG (1 : 4000) for 2 h and immuno binding was detected by the enhanced chemiluminescence method according to the manufacturer.
Exposure to cisplatin
The monolayers of cells were washed three times with HH buffer. Cisplatin was dissolved in dimethylsulfoxide (DMSO) just prior to the experiment and diluted in HH buffer. Two ml of cisplatin solution was added per well and 10 ml per 75 cm 2 culture flask; the cells were incubated for the indicated times at 378C in a 95% air/5% CO 2 atmosphere. Final concentrations of DMSO never exceeded 0.1%.
Cell detachment assay
Cells were cultured in six well dishes. The number of detached cells was determined by counting the cells using flow cytometry: after twice washing the monolayers in each well with 2 ml ice-cold PBS, the cells from each washing were pooled, centrifuged (80 g for 6 min at 48C), resuspended in 200 ml PBS, transferred to FACScan tubes and analyzed immediately, after addition of propidium iodide (PI) to a final concentration of 10 mM. Viability was determined by analyzing the PI fluorescence intensity with a FACScan flow cytometer. The number of detached cells was expressed as percentage of total cells present in the monolayer at t=0, i.e. the sum of the number of floating and attached cells. The latter were counted after harvesting the adherent cells by trypsinization.
Fixation and¯uorescent visualization of the cytoskeleton
At the indicated times, the buffer, containing cisplatin, was removed from the monolayers on the coverslips in the six well dish and each well was washed three times with 2 ml PBS pH 7.4. Cells were fixed for 20 min in 1.5 ml PBS containing 4% (w/v) formaldehyde at room temperature. After washing three times with 2 ml PBS, cells were incubated with 2 ml 0.1% (w/v) NaBH 4 in PBS for 10 min. Cells were washed three times with 2 ml PBS and incubated 10 min with 2 ml 0.1% (w/v) Triton-X-100 in PBS (PBS/triton) and subsequently with 2 ml 0.2% (w/v) BSA in PBS/triton (PBS/Triton/BSA) for 10 min prior to the staining.
F-actin was visualized using bodipy-phalloidin as follows: 80 ml phalloidin solution (1 : 40 dilution of 200 U/ml stock in methanol) was put on parafilm; the coverslip was put on top of the drop with the cells facing the staining solution for 20 min at room temp, in a dark and humidified chamber.
After staining, the cells were put back in the six well dishes and washed three times with 2 ml PBS/Triton/BSA and twice with 2 ml PBS. Cells were mounted in a drop of PBS 50% glycerol (w/v), containing 100 md/ml 1,4-diazobicyclo-octane (DABCO), sealed and stored at 7408C until analysis.
Fluorescence images were made using a video intensified fluorescence microscope (VIFM) system, with a IM35 inverted microscope (Zeiss, Oberkochen, Germany), equipped with a Nikon 40 X/1.3 NA CF Fluor objective. Images were recorded using a CCD instrumentation camera, controlled by a CC200 camera controller (Photometrics, Tucson, AZ, USA). Images were processed on an Imagine image processing system (Synoptics, Cambridge, UK) and stored on the hard disk of a Hewlett Packard 486 computer. Images were printed using a Mitshubishi colour video copy processor.
Quanti®cation of cell viability and percentage apoptotic cells by Acridine Orange/Ethidium Bromide uptake At the indicated times, the monolayers were washed twice with HH buffer, containing 2% (w/v) BSA, and the floating cells were pooled. Monolayers were stained with 2 ml buffer containing 10 mM acridine orange (AcOr) and 10 mM ethidium bromide (EtBr) for 1 min at room temperature on the coverslip and analyzed immediately using VIFM. Pooled cells were stained in 1 ml suspension with 10 mM of both dyes, mixed gently by hand; 10 ml of the cell suspension was put on a microscope slide, covered and analyzed immediately using VIFM. Cells were counted based on colour and appearance. Viable cells take up AcOr, giving them a green colour. Non-viable cells take up EtBr, giving them an orange colour. Both dyes intercalate into DNA, allowing separation 
Analysis of nuclear morphology in ®xed cells using Hoechst 33258
In some experiments, nuclear fragmentation was visualized in fixed cells. Fixation was performed as described above for staining of Factin. Apoptosis in fixed cells was determined by analyzing the morphology of the nucleus, after staining the cells with 80 ml of 2 mg/ml Hoechst 33258 in PBS for 20 min at room temperature. If applicable, cells were stained for F-actin and the nucleus simultaneously, by using one drop with both 2 mg/ml Hoechst 33258 and 5 U/ml bodipyphalloidin. Cells were classified apoptotic, depending on the condensation and fragmentation of the chromatin. For each treatment 1000 cells were analyzed using VIFM.
Northern and dot blot analysis
The monolayers were rinsed three times with ice-cold PBS, and total RNA was isolated from the cells as described elsewhere (Chirgwin et al, 1977) . Briefly, cells from one to three 75 cm 2 culture flasks were pooled in 10 ± 30 ml lytic solution and directly homogenized for 1 min on ice using an ultra-turrax T25 (Janke & Kunkel, IKA Labortechnik, Heitersheim, Germany).
Northern and dot blot analysis were performed as previously described (Church and Gilbert, 1984) . Aliquots of 20 mg RNA were denatured in a solution containing 50% (w/v) deionized formamide,
